BR100 Increased By (0.35%)
BR30 Increased By (1.33%)
KSE100 Increased By (0.47%)
KSE30 Increased By (0.43%)
BECO 5.43 Decreased By ▼ -0.06 (-1.09%)
BML 55.85 Decreased By ▼ -0.91 (-1.6%)
BOP 35.24 Increased By ▲ 0.12 (0.34%)
CNERGY 8.16 Increased By ▲ 0.01 (0.12%)
DCL 11.55 Increased By ▲ 0.04 (0.35%)
FCCL 57.61 Increased By ▲ 0.86 (1.52%)
FCSC 5.16 Increased By ▲ 0.01 (0.19%)
FFL 17.99 Increased By ▲ 0.11 (0.62%)
FNEL 1.26 Increased By ▲ 0.01 (0.8%)
HUMNL 11.10 Decreased By ▼ -0.02 (-0.18%)
KEL 8.64 Increased By ▲ 0.22 (2.61%)
KOSM 6.63 Increased By ▲ 0.05 (0.76%)
MLCF 105.61 Increased By ▲ 2.31 (2.24%)
NBP 201.00 Increased By ▲ 0.82 (0.41%)
PACE 11.35 Increased By ▲ 0.06 (0.53%)
PAEL 44.53 Increased By ▲ 1.06 (2.44%)
PIAHCLA 28.04 Increased By ▲ 0.55 (2%)
PIBTL 18.80 Increased By ▲ 1.10 (6.21%)
PPL 245.39 Increased By ▲ 1.07 (0.44%)
PRL 35.47 Increased By ▲ 0.04 (0.11%)
PTC 65.60 Increased By ▲ 0.25 (0.38%)
SEARL 94.99 Increased By ▲ 1.67 (1.79%)
SSGC 32.40 Decreased By ▼ -0.54 (-1.64%)
TELE 8.90 Decreased By ▼ -0.01 (-0.11%)
THCCL 66.89 Increased By ▲ 0.17 (0.25%)
TPLP 10.85 Increased By ▲ 0.02 (0.18%)
TREET 25.23 Increased By ▲ 0.11 (0.44%)
TRG 65.75 Increased By ▲ 0.85 (1.31%)
WAVES 10.90 Decreased By ▼ -0.03 (-0.27%)
WTL 1.26 Increased By ▲ 0.01 (0.8%)
اردو
Android App
Print Edition Dollar to PKR
Budget 2026-27 Iran-US war Petrol Prices Gold Rates Podcasts PSX Notices
Business & Finance

Bayer agrees to help make CureVac's COVID-19 vaccine

  • Bayer said it expects to produce 161 million doses of CureVac's experimental vaccine.
Published February 1, 2021 Updated February 1, 2021 02:58pm
Save
1 min
comment
By Reuters
Add BRecorder as a trusted
source on Google
Google Preferred Source

BERLIN: German pharmaceutical giant Bayer said on Monday it will help CureVac produce its experimental COVID-19 vaccine, the latest drugmaker to offer up manufacturing capacity as supplies fall behind demand.

Bayer said it expects to produce 161 million doses of CureVac's experimental vaccine, which is currently in late-stage testing, in 2022, its head of pharma Stefan Oelrich told a news conference.

drugmaker COVID19

Comments

Comments are closed for this article.

More Stories

Browse all stories